Intrinsic Value of S&P & Nasdaq Contact Us

Harpoon Therapeutics, Inc. HARP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$700.00
+2942.2%

Harpoon Therapeutics, Inc. (HARP) has 20 known insider and institutional holders on record. The largest holder is GADICKE ANSBERT with 6,371,704 shares. Other notable holders include MPM BioVentures 2014, L.P. and Arix Bioscience plc.

HARP Insider Ownership

Top Holder
GADICKE ANSBERT
6,371,704 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Gadicke Ansbert 10 Percent Owner 6,371,704 2021-06-02
100%
2 Mpm Bioventures 2014, L.p. Officer 3,223,567 2021-04-15
51%
3 Arix Bioscience Plc 10 Percent Owner 2,560,295 2020-05-29
40%
4 New Leaf Ventures Iii, L.p. 10 Percent Owner 913,860 2021-08-12
14%
5 Eastland Julia Marie President and CEO 232,003 2024-01-09
4%
6 Mcmahon Gerald Phd President and CEO 181,470 2021-01-29
3%
7 Sacks Natalie Chief Medical Officer 155,000 2022-02-01
2%
8 Walker Luke Nathaniel Chief Medical Officer 135,000 2024-01-09
2%
9 Wesche Holger Chief Scientific Officer 135,000 2022-02-01
2%
10 Erbez Georgia Chief Financial Officer 115,000 2022-02-01
2%
11 Bucher James B Chief Legal Officer 110,000 2023-12-26
2%
12 New Leaf Biopharma Opportunities Ii, L.p. 10 Percent Owner 85,750 2023-10-27
1%
13 Myers Scott Dunseth Director 22,666 2024-01-03
0%
14 Viney Joanne L. Director 21,028 2023-04-04
0%
15 Lanza Frank J Principal Fin. & Acctng Ofc. 18,362 2024-01-09
0%
16 Colowick Alan Director 16,456 2023-04-04
0%
17 Chin Mark Director 13,224 2024-03-11
0%
18 Hunt Ronald 10 Percent Owner 13,224 2024-03-11
0%
19 Drachman Jonathan G Director 5,415 2024-03-11
0%
20 Silvernail Lauren P Director 5,000 2023-11-28
0%

No ownership data available for HARP.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message